Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| Line 13: | Line 13: | ||
* [[Actos]] - Generic: [[Pioglitazone]] | * [[Actos]] - Generic: [[Pioglitazone]] | ||
* [[Avandia]] - Generic: [[Rosiglitazone]] | * [[Avandia]] - Generic: [[Rosiglitazone]] | ||
| - | =====Glucagon-like peptide-1 (GLP-1) agonist===== | + | =====[[Glucagon-like peptide 1 receptor|Glucagon-like peptide-1]] (GLP-1) agonist===== |
* [[Victoza]] - Generic: [[Liraglutide]] | * [[Victoza]] - Generic: [[Liraglutide]] | ||
=====Mechanism is not completely understood===== | =====Mechanism is not completely understood===== | ||
Revision as of 11:14, 10 July 2023
Insulin
Dipeptidyl Peptidase-4 Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
Glucagon-like peptide-1 (GLP-1) agonist
Mechanism is not completely understood
|
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
